SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZSAN (MC $30 M) NDA Submission & Partnership expected in Q4
ZSAN 1.470-1.3%Jan 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BioHero10/4/2019 11:14:01 AM
  Read Replies (1) of 6
 
NDA submission for Qtrypta approval and Partnership for the drug which means huge upfront payments still expected during this Quarter =MASSIVE upside potential here

ir.zosanopharma.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext